Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11,926.00
Bid: 11,924.00
Ask: 11,928.00
Change: 574.00 (5.06%)
Spread: 4.00 (0.034%)
Open: 11,890.00
High: 12,086.00
Low: 11,790.00
Prev. Close: 11,352.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monday broker round-up UPDATE

Mon, 13th Oct 2014 09:32

Amino Technologies: Northland Capital upgrades to buy with a target price of 100p.Anglo American: Canaccord Genuity initiates with a target price of 1720p and a buy recommendation. Credit Suisse upgrades to outperform with a target price of 1800p.Associated British Foods: Societe Generale upgrades to buy with a target price of 2950p.AstraZeneca: Jefferies raises target price from 4500p to 5000p upgrading to buy.Betfair Group: Numis reduces target price from 1250p to 940p downgrading to reduce.Bodycote: Investec cuts target price from 775p to 750p and stays with its buy recommendation.Brammer: Investec cuts target price from 435p to 400p, while keeping a buy recommendation.Brown (N) Group: N+1 Singer reduces target price from 585p to 390p, while staying with its buy recommendation. Jefferies cuts target price from 540p to 406p and reiterates a buy recommendation.BTG: Investec raises target price from 728p to 832p staying with its buy recommendation.bwin.party: Numis cuts target price from 200p to 180p and keeps a buy recommendation.Coca-Cola HBC: Credit Suisse reduces target price from 1500p to 1400p, while maintaining its neutral rating.Dialight: Investec reduces target price from 910p to 850p downgrading to sell.Domino Printing: Investec cuts target price from 650p to 615p keeping an add rating.Eagle Eye: Panmure Gordon initiates with a target price of 229p and a buy recommendation.Fenner: Investec cuts target price from 320p to 270p and retains a sell recommendation.Ferrexpo: Cantor Fitzgerald reduces target price from 250p to 120p maintaining a buy recommendation.GKN: Investec cuts target price from 380p to 330p, while upgrading from add to buy.GlaxoSmithKline: Jefferies ups target price from 1385p to 1400p and retains a hold recommendation.Glencore: Canaccord Genuity initiates with a target price of 400p and a buy recommendation.Halma: Investec lowers target price from 635p to 630p and maintains a buy recommendation.Hellermann Tyton: Investec lowers target price from 305p to 300p and retains a hold recommendation.IMI: Investec reduces target price from 1560p to 1425p and keeps a buy recommendation.IMImobile: WH Ireland ups target price from 175p to 187p and retains a buy recommendation.Jupiter Fund Management: JP Morgan cuts target price from 465p to 400p staying with an overweight rating. Espirito Santo cuts target price from 489p to 469p leaving its buy recommendation unaltered.Ladbrokers: Numis reduces target price from 150p to 100p downgrading to reduce.Laird: Investec lowers target price from 260p to 250p leaving its sell recommendation unchanged.Melrose: Investec shifts target price from 332p to 335p and keeps a buy recommendation.Molins: Panmure Gordon reduces target price from 250p to 165p and stays with its buy recommendation.Morgan Advanced Materials: Investec lowers target price from 345p to 335p reiterating its buy recommendation.Oxford Instruments: Investec reduces target price from 1520p to 1405p and reiterates a buy recommendation.Paragon Group: JP Morgan ups target price from 396p to 420p and leaves its overweight rating unchanged.Playtech: Numis cuts target price from 700p to 665p and reiterates a hold recommendation.Renishaw: Investec reduces target price from 1900p to 1775p keeping a buy recommendation.Rotork: Investec reduces target price from 2840p to 2610p retaining its add rating.Smith (DS): Investec cuts target price from 380p to 350p and stays with its buy recommendation.Smith & Nephew: Investec reduces target price from 1100p to 1023p and downgrades from add to hold.Smith (WH): Canaccord Genuity initiates with a target price of 1225p and a buy recommendation.Spectris: Investec reduces target price from 2580p to 2380p and maintains a buy recommendation.Spirax-Sarco: Investec reduces target price from 2920p to 2810p and stays with its add rating.TSB: Investec shifts target price from 290p to 295p upgrading from hold to buy.Vedanta Resources: Canaccord Genuity initiates with a target price of 1020p and a hold recommendation. JP Morgan lowers target price from 1140p to 1130p and retains its neutral rating.Vesuvius: Investec cuts target price from 485p to 450p and reiterates an add rating.Vitec Group: Investec cuts target price from 790p to 740p maintaining a buy recommendation.Weir Group: Investec raises target price from 2400p to 2525p, but still recommends selling.William Hill: Numis reduces target price from 500p to 400p downgrading to add.888 Holdings: Numis cuts target price from 220p to 175p and keeps a buy recommendation.32Red: Numis lowers target price from 100p to 80p, while retaining its buy recommendation.
More News
Today 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
Today 08:31

AstraZeneca leaps after smashing first quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
Today 07:56

REPEAT: Miner Anglo American reviews takeover bid from rival BHP

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
Today 07:52

Sanofi profit slips on generic competition and currency effects

April 25 (Reuters) - Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent, the French drugmaker said on Thursday.

Read more
Today 07:43

LONDON BRIEFING: Miner Anglo American eyes rival BHP takeover

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
Today 06:30

Sanofi Q1 profit slips on generic competition, forex effects

April 25 (Reuters) - Sanofi's said on Thursday first-quarter operating income declined 14.7% as unfavourable currency effects and cheap competition to multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent.

Read more
24 Apr 2024 10:32

Angle shares jump on supplier agreement with with AstraZeneca

(Alliance News) - Angle PLC shares rose on Wednesday, after it signed a contract with AstraZeneca PLC.

Read more
24 Apr 2024 10:10

AIM WINNERS & LOSERS: Filtronic jumps as lifts outlook

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
18 Apr 2024 14:17

UK earnings, trading statements calendar - next 7 days

Friday 19 April 
888 Holdings PLCTrading Statement
Man Group PLCTrading Statement
Monday 22 April 
Brave Bison Group PLCFull Year Results
Elixirr International PLCFull Year Results
Frenkel Topping Group PLCFull Year Results
Mobico Group PLCFull Year Results
South32 LtdQ3 Results
Ten Lifestyle Group PLCHalf Year Results
Tuesday 23 April 
Alliance Pharma PLCFull Year Results
Alphawave IP Group PLCFull Year Results
Anglo American PLCTrading Statement
ASA International Group PLCFull Year Results
Associated British Foods PLCHalf Year Results
Eleco PLCFull Year Results
GB Group PLCTrading Statement
Jupiter Fund Management PLCTrading Statement
Maintel Holdings PLCFull Year Results
Property Franchise Group PLCFull Year Results
Taylor Wimpey PLCTrading Statement
tinyBuild IncFull Year Results
Trellus Health PLCFull Year Results
Wednesday 24 April 
1Spatial PLCFull Year Results
abrdn PLCTrading Statement
Ecora Resources PLCTrading Statement
Fresnillo PLCTrading Statement
Lloyds Banking Group PLCQ1 Results
Nichols PLCTrading Statement
PensionBee Group PLCFirst Quarter Results
PZ Cussons PLCTrading Statement
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Serica Energy PLCFull Year Results
Star Energy Group PLCFull Year Results
Tortilla Mexican Grill PLCFull Year Results
Tracsis PLCHalf Year Results
Warpaint London PLCFull Year Results
Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Hikma Pharmaceuticals PLCTrading Statement
Focusrite PLCHalf Year Results
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
16 Apr 2024 09:48

LONDON BROKER RATINGS: RBC raises Admiral; Barclays cuts Phoenix Group

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
16 Apr 2024 09:30

Boehringer replaces Bayer as Germany's largest drugmaker on Jardiance gains

INGELHEIM, Germany, April 16 (Reuters) - Boehringer Ingelheim on Tuesday overtook Bayer as Germany's largest drugmaker when the unlisted company reported a currency-adjusted gain in 2023 pharmaceutical sales of 10.3% to 20.8 billion euros ($22.11 billion).

Read more
16 Apr 2024 08:39

AstraZeneca's hails Imfinzi survival data on cancer form

(Alliance News) - AstraZeneca PLC on Tuesday said that its immunotherapy Imfinzi showed positive survival rate in people with advanced biliary tract cancer.

Read more
12 Apr 2024 12:55

EU regulator rules out link between weight-loss drugs and suicidal thoughts

April 12 (Reuters) - The European Union drug regulator found no evidence that a class of diabetes and weight-loss drugs such as Novo Nordisk's hugely popular Wegovy, are linked to suicidal thoughts, it said on Friday, ending a nine-month probe.

Read more
11 Apr 2024 18:51

AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition

Policy approved with two-third of votes in favour

*

Read more
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.